“…but not yet in clinical application, include Zr-(18.46-18.79)Nb-(0.47-1.1)Si (wt.%), [104] Zr-(19.5-20.5)Nb-(0.1-15)Ti (wt.%), [105] Zr-(16-50)Ta (wt.%), [106] and Ti-(10-20)Nb-(1-50)Zr (wt.%). [107] In addition, there are Zr-based BMGs, which are patented for biomedical application such as Zr50-x Al10Cu40Rex (at.%) (RE = Y or La or Ce or Nd, Sm, Gd or Dy or Ho or Er, Tm or Lu; X is 0 < X ≤10), [108] (60-70)Zr-25Ti-2.5Nb-7.5Al-15Fe-15Cu-10Ag-10Pd, [109] Zr48Cu45-x Al7Agx, (1 < X <10), [110] (ZraTib ), [111] [(ZrxCu100−x)a(EyG100−y)100−a]100−bZb, (70≤a≤90, x≥50, y>0, and 0≤b≤6). [112] A u t h o r M a n u s c r i p t…”